The US Food and Drug Administration has approved mirdametinib for the treatment of neurofibromatosis type 1 (NF1) in adults ...

Enzyme designers in the David Baker lab at the University of Washington in Seattle, from left: Sam Pellock, Anna Lauko, Kiera ...

Nobel Laureate Prof. Aaron Ciechanover (2004, Chemistry) delivered a special address at the inaugural of ProUPS (Proteostasis ...

AI accelerates drug development, cutting costs and boosting success rates. Discover how AI is reshaping the future of ...

SYDNEY, Feb. 14 (Xinhua) -- Australian researchers have for the first time introduced genetic material into plants via their roots in a breakthrough they said could boost crop yield and food quality.

By analyzing E. coli protein levels, scientists found a surplus of membrane shuttle proteins that may play a role in ...

New research uses AI to engineer enzymes with intricate active sites, expanding the possibilities for synthetic biocatalysts.